Search Within

Jamie Erin Chaft

Formats
  1. Meeting Abstract (146)
  2. Journal Article (127)
  3. Review (9)
  4. Editorial (2)
  5. Miscellaneous (2)
  6. Conference Paper (1)
  7. Guidelines (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (289)
  2. Solid Tumor Oncology Division (289)
  3. Thoracic Oncology (289)
  4. Surgery (112)
  5. Department of Pathology and Laboratory Medicine (96)
  6. GSK Faculty (76)

More Groups

People
  1. Mark Kris (107)
  2. Matthew Hellmann (68)
  3. Andreas Rimner (59)
  4. David Jones (49)
  5. Abraham Wu (47)
  6. Valerie Rusch (47)

More People

Years
  1. 2025 (5)
  2. 2024 (29)
  3. 2023 (28)
  4. 2022 (23)
  5. 2021 (23)
  6. 2020 (20)

More Years

Publications
  1. Journal of Thoracic Oncology (60)
  2. Journal of Clinical Oncology (57)
  3. International Journal of Radiation Oncology, Biology, Physics (25)
  4. Annals of Oncology (13)
  5. Journal of Thoracic and Cardiovascular Surgery (10)
  6. Clinical Cancer Research (9)

More Publications

Publishers
  1. Elsevier Inc. (102)
  2. American Society of Clinical Oncology (61)
  3. American Association for Cancer Research (23)
  4. Oxford University Press (16)
  5. Nature Publishing Group (11)
  6. Mosby Elsevier (10)

More Publishers

Results (289)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of atezolizumab as neoadjuvant and adjuvant therapy in patients (pts) with resectable non small cell lung cancer (NSCLC)
    Meeting Abstract

    Owen, D.; Bunn, P. Jr; Johnson, B.; Kwiatkowski, D.; Kris, M.; Wistuba, I.; Gandhi, M.; Phan, S.; Shames, D.; Schulze, K.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • SBRT and sequential chemotherapy for stage IIA to IIIA non-small cell lung cancer - A phase I dose escalation study
    Meeting Abstract

    Von Reibnitz, D.; Chaft, J.; Wu, A.; Gelblum, D.; Yorke, E.; Gelb, E.; Mitchell, S.; Ng, K.; Rimner, A.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Atezolizumab as 1L therapy for advanced NSCLC in PD-L1 selected patients: Updated ORR, PFS and OS data from the BIRCH study
    Meeting Abstract

    Garassino, M.; Rizvi, N.; Besse, B.; Jänne, P.; Christoph, D.; Peters, S.; Toh, C. K.; Kurata, T.; Costa, E. C.; Koczywas, M.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Liquid biopsy for ctDNA to revolutionize the care of patients with early stage lung cancers
    Journal Article

    Li, B. T.; Stephens, D.; Chaft, J. E.; Rudin, C. M.; Jones, D. R.; Rusch, V. W.; Rimner, A.; Isbell, J. M.
    Annals of Translational Medicine (2017)

    Fulltext@MSK | Save
  • Tumor spread through airspaces and histologic subtype predict outcomes following post-operative radiation therapy for locally advanced lung adenocarcinoma
    Meeting Abstract

    Leeman, J. E.; Shepherd, A. F.; Wild, A.; Imber, B. S.; Pei, X.; Gelb, E.; Yorke, E. D.; Travis, W.; Adusumilli, P.; Jones, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Prognostic impact of tumor location and lymph node burden for patients with stage IIIA non-small cell lung cancer receiving postoperative radiation therapy
    Meeting Abstract

    Imber, B. S.; Leeman, J. E.; Shepherd, A. F.; Wild, A.; Pei, X.; Gelb, E.; Chaft, J.; Mychalczak, B. R.; Jones, D.; Isbell, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • A comparison of trimodality therapy versus definitive concurrent chemoradiation in patients with stage IIIA non-small cell lung cancer
    Meeting Abstract

    Shepherd, A. F.; Leeman, J. E.; Wild, A.; Imber, B. S.; Pei, X.; Gelb, E.; Yorke, E. D.; Isbell, J.; Chaft, J.; Gelblum, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • FDG-PET maximum standardized uptake value is prognostic for survival and disease-free survival in stage IIIA-N2 non-small cell lung cancer patients who receive postoperative radiation therapy
    Meeting Abstract

    Wild, A.; Shepherd, A. F.; Leeman, J. E.; Imber, B. S.; Pei, X.; Gelblum, D.; Gelb, E.; Chaft, J.; Jones, D.; Isbell, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Atezolizumab as 1L therapy for advanced NSCLC in PD-L1-selected patients: Updated ORR, PFS and OS data from the BIRCH study
    Meeting Abstract

    Eberhardt, W. E. E.; Garassino, M. C.; Rizvi, N. A.; Jänne, P. A.; Christoph, D.; Peters, S.; Toh, C. K.; Kurata, T.; Costa, E. C.; Koczywas, M.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • Adjuvant systemic therapy and adjuvant radiation therapy for stage I to IIIA completely resected non-small-cell lung cancers: American Society of Clinical Oncology/Cancer Care Ontario clinical practice guideline update
    Journal Article

    Kris, M. G.; Gaspar, L. E.; Chaft, J. E.; Kennedy, E. B.; Azzoli, C. G.; Ellis, P. M.; Lin, S. H.; Pass, H. I.; Seth, R.; Shepherd, F. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save